D
Daniel J. Lenihan
Researcher at Vanderbilt University Medical Center
Publications - 166
Citations - 9052
Daniel J. Lenihan is an academic researcher from Vanderbilt University Medical Center. The author has contributed to research in topics: Heart failure & Cancer. The author has an hindex of 32, co-authored 140 publications receiving 6193 citations. Previous affiliations of Daniel J. Lenihan include Vanderbilt University.
Papers
More filters
Journal ArticleDOI
Cardiac events during treatment with proteasome inhibitor therapy for multiple myeloma
TL;DR: AEs were common in patients receiving PIs and Choice of PI did not impact the cumulative incidence of CAEs, and a history of prior cardiac events and longer duration of PI therapy were identified as independent risk factors for developing CAEs.
Journal ArticleDOI
Tachycardia-induced cardiomyopathy: atrial fibrillation and congestive heart failure.
TL;DR: A case of a patient with atrial fibrillation with rapid ventricular response who showed a dramatic improvement in left ventricular function following AV nodal ablation and insertion of a pacemaker is presented.
Journal ArticleDOI
Institutional Volume of Heart Transplantation with Left Ventricular Assist Device Explantation Influences Graft Survival
Nicholas A. Haglund,Irene D. Feurer,Rashid M. Ahmad,Thomas G. DiSalvo,Daniel J. Lenihan,Mary E. Keebler,Kelly Schlendorf,John M. Stulak,Mark Wigger,Simon Maltais +9 more
TL;DR: Graft survival is decreased when performed at centers falling in the lowest quartile of LVAD explant-OHT for a given year, and this volume-survival relationship should be considered in the context of limited donor organ availability and the rapidly growing number of LVad centers.
Journal ArticleDOI
Evidence for association of coronary sinus levels of hepatocyte growth factor and collateralization in human coronary disease
TL;DR: These data map for the first time the concentration of endogenous angiogenic factors in the coronary circulation and support further studies to determine whether HGF may be an endogenous cardioprotectiveAngiogenic factor.
Journal ArticleDOI
Are Peripherally Inserted Central Catheters Associated With Increased Risk of Adverse Events in Status 1B Patients Awaiting Transplantation on Continuous Intravenous Milrinone
Nicholas A. Haglund,Zachary L. Cox,Jeff Lee,Yanna Song,Mary E. Keebler,Thomas G. DiSalvo,Simon Maltais,Daniel J. Lenihan,Mark Wigger +8 more
TL;DR: PICC AEs accounted for increased intensive care unit admissions, HT list inactivations, and overall cost, and PICCs with >1 lumen were associated with increased risk of infection.